V Suzanne Klimberg Selected Research

V Suzanne Klimberg Research Topics

Disease

42	Neoplasms (Cancer) 01/2022 - 05/2003
39	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2003
8	Cardiotoxicity 02/2020 - 07/2009
6	Lymphedema (Milroy Disease) 11/2019 - 06/2007
4	Genetic Predisposition to Disease (Genetic Predisposition) 10/2018 - 01/2015
4	Carcinogenesis 05/2008 - 05/2003
3	Ductal Carcinoma 04/2022 - 10/2018
3	Hematoma 10/2018 - 01/2007
2	Triple Negative Breast Neoplasms 01/2013 - 10/2012
2	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2011 - 07/2006
2	Pain (Aches) 11/2008 - 10/2004
1	Wounds and Injuries (Trauma) 04/2022
1	Polyps 01/2022
1	Lobular Carcinoma 01/2022
1	Neoplasm Micrometastasis 12/2021
1	Body Weight (Weight, Body) 02/2020
1	Hypersensitivity (Allergy) 09/2017
1	Drug-Related Side Effects and Adverse Reactions 09/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2017
1	Inflammation (Inflammations) 06/2017
1	Insulin Resistance 06/2017
1	Neoplasm Metastasis (Metastasis) 04/2017
1	Hyperthermia 04/2014
1	Radiation Injuries (Radiation Sickness) 09/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Melanoma (Melanoma, Malignant) 01/2011
1	Bursitis (Adhesive Capsulitis) 10/2010

Drug/Important Bio-Agent (IBA)

16	Glutamine (L-Glutamine)FDA Link 10/2018 - 05/2003
11	Glutathione (Reduced Glutathione)IBA 02/2011 - 05/2003
8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2020 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2006
5	anthraceneIBA 05/2008 - 11/2003
4	Hormones (Hormone)IBA 01/2022 - 01/2007
4	Estrogen ReceptorsIBA 12/2021 - 07/2006
4	Antineoplastic Agents (Antineoplastics)IBA 09/2017 - 07/2010
4	Coloring Agents (Dyes)IBA 11/2014 - 06/2004
3	Progesterone Receptors (Progesterone Receptor)IBA 12/2021 - 07/2006
3	Pharmaceutical PreparationsIBA 11/2019 - 10/2006
3	EnzymesIBA 01/2010 - 01/2008
3	Caspase 3 (Caspase-3)IBA 01/2010 - 12/2004
3	Messenger RNA (mRNA)IBA 01/2008 - 12/2004
3	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2006 - 05/2003
2	CalciumIBA 02/2020 - 11/2019
2	Phenobarbital (Luminal)FDA Link 10/2018 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 01/2006
2	Amino Acids FDA Link 06/2017 - 11/2003
2	Biological ProductsIBA 01/2015 - 01/2015
2	Blood Proteins (Serum Proteins)IBA 09/2013 - 10/2006
2	SulfurIBA 10/2011 - 06/2004
2	Radioisotopes (Radionuclides)IBA 10/2011 - 06/2004
2	Colloids (Colloid)IBA 10/2011 - 06/2004
2	AntioxidantsIBA 02/2011 - 01/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 07/2009
2	Free RadicalsIBA 07/2010 - 01/2010
2	salicylhydroxamic acid (SHAM)IBA 01/2010 - 01/2007
2	Insulin-Like Growth Factor I (IGF-1)IBA 11/2003 - 05/2003
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	tear proteinsIBA 01/2022
1	TrypsinIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	ProteomeIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 12/2021
1	Dantrolene (Dantrium)FDA LinkGeneric 02/2020
1	Troponin IIBA 02/2020
1	2,6-dinitrotoluene (DNT)IBA 02/2020
1	ThiazidesIBA 11/2019
1	Antihypertensive Agents (Antihypertensives)IBA 11/2019
1	AnthracyclinesIBA 11/2019
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 11/2019
1	serum P-component (CIt)IBA 10/2018
1	CitrullineIBA 10/2018
1	IsotopesIBA 10/2018
1	Arginine (L-Arginine)FDA Link 10/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018
1	HLA-C Antigens (HLA-C)IBA 09/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2017
1	micaIBA 09/2017
1	A-factor (Streptomyces)IBA 01/2013
1	Rh-Hr Blood-Group System (Rhesus Blood-Group System)IBA 10/2012
1	Tumor Biomarkers (Tumor Markers)IBA 10/2011
1	Technetium (Technetium 99m)IBA 01/2011
1	Local AnestheticsIBA 10/2010

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2022 - 12/2004
13	Segmental Mastectomy (Lumpectomy) 10/2021 - 08/2003
12	Therapeutics 10/2021 - 10/2006
7	Mastectomy (Mammectomy) 04/2022 - 10/2004
5	Radiotherapy 04/2017 - 09/2013
5	Radiofrequency Ablation 04/2014 - 04/2007
4	Lymph Node Excision (Lymph Node Dissection) 02/2021 - 05/2008
3	Operative Surgical Procedures 06/2017 - 01/2015
2	Adjuvant Chemotherapy 01/2022 - 02/2021
2	Neoadjuvant Therapy 04/2015 - 04/2011
2	Anesthesia 10/2011 - 06/2006
2	Lasers (Laser) 10/2011 - 10/2006
1	Radical Mastectomy 10/2017
1	Nutritional Support (Artificial Feeding) 06/2017
1	Prophylactic Mastectomy 01/2015
1	Metronomic Administration 01/2011